Montreal, Canada

Gregory Opiteck




Average Co-Inventor Count = 5.7

ph-index = 2

Forward Citations = 14(Granted Patents)


Location History:

  • Lawrenceville, NJ (US) (2008)
  • Montreal, CA (2009 - 2011)

Company Filing History:


Years Active: 2008-2011

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Gregory Opiteck: Innovator in Biological Analysis and Disease Treatment

Introduction

Gregory Opiteck is a notable inventor based in Montreal, Canada. He has made significant contributions to the field of biological analysis and disease treatment through his innovative patents. With a total of 3 patents, Opiteck's work focuses on methods that enhance our understanding of biological molecules and their implications in health.

Latest Patents

One of Opiteck's latest patents is a method of analyzing differential expression of proteins in proteomes by mass spectrometry. This method identifies molecules of biological origin based on their accurately determined mass to charge ratio and additional physico-chemical properties. The ability to recognize and identify the same molecules in different samples allows researchers to determine variations in biological expression, which is crucial for experimental analysis.

Another significant patent involves methods of diagnosing tumors using the G-protein coupled receptor (GPCR), RAI-3. This invention identifies a GPCR family member that is modified and associated with activation complexes after exposure to cigarette smoke. The RAI-3 protein serves as a potential drug target for treating chronic obstructive pulmonary disease (COPD) and related disorders. Opiteck's work in this area opens new avenues for therapeutic interventions in diseases linked to tobacco exposure.

Career Highlights

Throughout his career, Gregory Opiteck has worked with prominent companies such as Bristol-Myers Squibb Company and Micromass UK Limited. His experience in these organizations has contributed to his expertise in biological research and innovation.

Collaborations

Opiteck has collaborated with notable colleagues, including Leah Ann Garulacan and Stephen K. Durham. These partnerships have likely enriched his research and development efforts, fostering a collaborative environment for innovation.

Conclusion

Gregory Opiteck's contributions to the fields of biological analysis and disease treatment through his patents demonstrate his commitment to advancing scientific knowledge. His innovative methods and collaborations continue to impact the understanding and treatment of significant health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…